메뉴 건너뛰기




Volumn 25, Issue 1, 2010, Pages 89-95

Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo

Author keywords

Cathepsin B; Gastrin; Peptides

Indexed keywords

CATHEPSIN B; CHOLECYSTOKININ B RECEPTOR; GASTRIN; INDIUM 111; LYSOSOME ENZYME; NEUROPEPTIDE; INDIUM; PEPTIDE FRAGMENT; RADIOPHARMACEUTICAL AGENT;

EID: 77649293783     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2009.0666     Document Type: Article
Times cited : (26)

References (7)
  • 1
    • 33749017931 scopus 로고    scopus 로고
    • Cysteine cathepsins: Multifunctional enzymes in cancer
    • Mohamed MM, Sloane BF. Cysteine cathepsins: Multifunctional enzymes in cancer. Nat Rev Cancer 2006;6:764.
    • (2006) Nat Rev Cancer , vol.6 , pp. 764
    • Mohamed, M.M.1    Sloane, B.F.2
  • 2
    • 34648815810 scopus 로고    scopus 로고
    • Emerging roles of proteases in tumour suppression
    • Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007;7:800.
    • (2007) Nat Rev Cancer , vol.7 , pp. 800
    • Lopez-Otin, C.1    Matrisian, L.M.2
  • 3
    • 0023141221 scopus 로고
    • Anti-cancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro
    • Duncan R, Kopeckova-Rejmanova P, Strohalm J, et al. Anti-cancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer 1987;55:165.
    • (1987) Br J Cancer , vol.55 , pp. 165
    • Duncan, R.1    Kopeckova-Rejmanova, P.2    Strohalm, J.3
  • 4
    • 1542743561 scopus 로고    scopus 로고
    • Evaluation of a cathepsin-cleavable peptide-linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients
    • DeNardo GL, DeNardo SJ. Evaluation of a cathepsin-cleavable peptide-linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients. Cancer Biother Radiopharm 2004;19:85.
    • (2004) Cancer Biother Radiopharm , vol.19 , pp. 85
    • DeNardo, G.L.1    DeNardo, S.J.2
  • 5
    • 23844507146 scopus 로고    scopus 로고
    • High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human antimouse antibody
    • Richman CM, Denardo SJ, O'Donnell RT, et al. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human antimouse antibody. Clin Cancer Res 2005; 11:5920.
    • (2005) Clin Cancer Res , vol.11 , pp. 5920
    • Richman, C.M.1    Denardo, S.J.2    O'Donnell, R.T.3
  • 6
    • 34248586422 scopus 로고    scopus 로고
    • Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy
    • Mather SJ, McKenzie AJ, Sosabowski JK, et al. Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy. J Nucl Med 2007;48:615.
    • (2007) J Nucl Med , vol.48 , pp. 615
    • Mather, S.J.1    McKenzie, A.J.2    Sosabowski, J.K.3
  • 7
    • 0037122778 scopus 로고    scopus 로고
    • Design of novel bioconju-gates for targeted drug delivery
    • Lu ZR, Shiah JG, Sakuma S, et al. Design of novel bioconju-gates for targeted drug delivery. J Contr Rel 2002;78:165.
    • (2002) J Contr Rel , vol.78 , pp. 165
    • Lu, Z.R.1    Shiah, J.G.2    Sakuma, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.